411 related articles for article (PubMed ID: 15610036)
21. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
Udit AK; Arnold FH; Gray HB
J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
[TBL] [Abstract][Full Text] [Related]
22. Substrate binding-induced changes in the EPR spectra of the ferrous nitric oxide complexes of neuronal nitric oxide synthase.
Migita CT; Salerno JC; Masters BS; Martasek P; McMillan K; Ikeda-Saito M
Biochemistry; 1997 Sep; 36(36):10987-92. PubMed ID: 9283090
[TBL] [Abstract][Full Text] [Related]
23. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
[TBL] [Abstract][Full Text] [Related]
24. Spectral properties of the oxyferrous complex of the heme domain of cytochrome P450 BM-3 (CYP102).
Bec N; Anzenbacher P; Anzenbacherová E; Gorren AC; Munro AW; Lange R
Biochem Biophys Res Commun; 1999 Dec; 266(1):187-9. PubMed ID: 10581187
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 BM3, NO binding and real-time NO detection.
Ost TW; Liu S; Daff S
Nitric Oxide; 2011 Aug; 25(2):89-94. PubMed ID: 21296178
[TBL] [Abstract][Full Text] [Related]
26. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
27. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamic and kinetic studies on the binding of nitric oxide to a new enzyme mimic of cytochrome p450.
Franke A; Hessenauer-Ilicheva N; Meyer D; Stochel G; Woggon WD; van Eldik R
J Am Chem Soc; 2006 Oct; 128(41):13611-24. PubMed ID: 17031976
[TBL] [Abstract][Full Text] [Related]
29. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide.
Stone JR; Marletta MA
Biochemistry; 1996 Jan; 35(4):1093-9. PubMed ID: 8573563
[TBL] [Abstract][Full Text] [Related]
30. A tryptophan that modulates tetrahydrobiopterin-dependent electron transfer in nitric oxide synthase regulates enzyme catalysis by additional mechanisms.
Wang ZQ; Wei CC; Santolini J; Panda K; Wang Q; Stuehr DJ
Biochemistry; 2005 Mar; 44(12):4676-90. PubMed ID: 15779894
[TBL] [Abstract][Full Text] [Related]
31. Phe393 mutants of cytochrome P450 BM3 with modified heme redox potentials have altered heme vinyl and propionate conformations.
Chen Z; Ost TW; Schelvis JP
Biochemistry; 2004 Feb; 43(7):1798-808. PubMed ID: 14967021
[TBL] [Abstract][Full Text] [Related]
32. Novel haem co-ordination variants of flavocytochrome P450BM3.
Girvan HM; Toogood HS; Littleford RE; Seward HE; Smith WE; Ekanem IS; Leys D; Cheesman MR; Munro AW
Biochem J; 2009 Jan; 417(1):65-76. PubMed ID: 18721129
[TBL] [Abstract][Full Text] [Related]
33. Irreversible inhibition of cytochrome P450 by nitric oxide.
Minamiyama Y; Takemura S; Imaoka S; Funae Y; Tanimoto Y; Inoue M
J Pharmacol Exp Ther; 1997 Dec; 283(3):1479-85. PubMed ID: 9400024
[TBL] [Abstract][Full Text] [Related]
34. The role of Thr268 and Phe393 in cytochrome P450 BM3.
Clark JP; Miles CS; Mowat CG; Walkinshaw MD; Reid GA; Daff SN; Chapman SK
J Inorg Biochem; 2006 May; 100(5-6):1075-90. PubMed ID: 16403573
[TBL] [Abstract][Full Text] [Related]
35. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
[TBL] [Abstract][Full Text] [Related]
36. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
[TBL] [Abstract][Full Text] [Related]
37. Flavocytochrome P450 BM3 mutant W1046A is a NADH-dependent fatty acid hydroxylase: implications for the mechanism of electron transfer in the P450 BM3 dimer.
Girvan HM; Dunford AJ; Neeli R; Ekanem IS; Waltham TN; Joyce MG; Leys D; Curtis RA; Williams P; Fisher K; Voice MW; Munro AW
Arch Biochem Biophys; 2011 Mar; 507(1):75-85. PubMed ID: 20868649
[TBL] [Abstract][Full Text] [Related]
38. Resonance Raman studies of cytochrome P450BM3 and its complexes with exogenous ligands.
Deng TJ; Proniewicz LM; Kincaid JR; Yeom H; Macdonald ID; Sligar SG
Biochemistry; 1999 Oct; 38(41):13699-706. PubMed ID: 10521277
[TBL] [Abstract][Full Text] [Related]
39. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
40. 4-cyanopyridine, a versatile spectroscopic probe for cytochrome P450 BM3.
Ost TW; Clark JP; Anderson JL; Yellowlees LJ; Daff S; Chapman SK
J Biol Chem; 2004 Nov; 279(47):48876-82. PubMed ID: 15364917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
